3:首次持股聲明-高管 JONES WILLIAM A JR
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-高管 Audet Juliette Berangere
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-董事 Topper James N
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-高管 Kastelein Johannes Jacob Pieter
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | SC 13D/A:超過5%持股股東披露文件(修正)-BCLS Fund III Investments, LP(6.0%),BCLS II Investco, LP(5.4%)等
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-董事 LANGE LOUIS G
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | SC 13D/A:超過5%持股股東披露文件(修正)-James N. Topper(14.2%),Patrick J. Heron(14.2%)等
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(9.9%),Peter Kolchinsky(9.9%)等
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-Viking Global Investors LP(9.7%),Viking Global Opportunities Parent GP LLC(9.7%)等
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 3/A:首次持股聲明(修正)-高管 Davidson Michael H.
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 3/A:首次持股聲明(修正)-董事 LANGE LOUIS G
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-董事 Lewis William
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 3:首次持股聲明-董事 Lewis William
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-高管 Kooij Louise Frederika
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-高管 Kling Douglas F
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-董事 van der Kamp Hilde Johanna
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-董事 Smither John W
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-高管 Kastelein Johannes Jacob Pieter
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-董事 LANGE LOUIS G
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 4:持股變動聲明-高管 Davidson Michael H.
暫無數據